Time of metastatic disease presentation and volume of disease are prognostic for metastatic hormone sensitive prostate cancer (mHSPC)

The Prostate, EarlyView.

Source: The Prostate - April 30, 2018 Category: Urology & Nephrology Authors: Edoardo Francini , Kathryn P. Gray , Wanling Xie , Grace K. Shaw , Loana Valen ça , Brandon Bernard , Laurence Albiges , Lauren C. Harshman , Philip W. Kantoff , Mary‐Ellen Taplin , Cristopher J. Sweeney Source Type: research